• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在妊娠早期维持内皮糖蛋白血管内皮生长因子以建立妊娠诱导的高血压动物模型。

EG-VEGF Maintenance Over Early Gestation to Develop a Pregnancy-Induced Hypertensive Animal Model.

作者信息

Reynaud Déborah, Sergent Frédéric, Abi Nahed Roland, Brouillet Sophie, Benharouga Mohamed, Alfaidy Nadia

机构信息

Unité U1036, Institut National de la Santé et de la Recherche Médicale, Grenoble, France.

University Grenoble-Alpes, 38000, Grenoble, France.

出版信息

Methods Mol Biol. 2018;1710:317-324. doi: 10.1007/978-1-4939-7498-6_25.

DOI:10.1007/978-1-4939-7498-6_25
PMID:29197014
Abstract

During the last decade, multiple animal models have been developed to mimic hallmarks of pregnancy-induced hypertension (PIH) diseases, which include gestational hypertension, preeclampsia (PE), or eclampsia. Converging in vitro, ex vivo, and clinical studies from our group strongly suggested the potential involvement of the new angiogenic factor EG-VEGF (endocrine gland-derived-VEGF) in the development of PIH. Here, we described the protocol that served to demonstrate that maintenance of EG-VEGF production over 11.5 days post coitus (dpc) in the gravid mice caused the development of PIH. The developed model exhibited most hallmarks of preeclampsia.

摘要

在过去十年中,已经开发出多种动物模型来模拟妊娠高血压疾病(PIH)的特征,其中包括妊娠高血压、子痫前期(PE)或子痫。我们团队进行的体外、离体和临床研究一致有力地表明,新的血管生成因子EG-VEGF(内分泌腺源性VEGF)可能参与了PIH的发展。在此,我们描述了一个实验方案,该方案用于证明妊娠小鼠在交配后11.5天(dpc)以上维持EG-VEGF的产生会导致PIH的发生。所建立的模型表现出子痫前期的大多数特征。

相似文献

1
EG-VEGF Maintenance Over Early Gestation to Develop a Pregnancy-Induced Hypertensive Animal Model.在妊娠早期维持内皮糖蛋白血管内皮生长因子以建立妊娠诱导的高血压动物模型。
Methods Mol Biol. 2018;1710:317-324. doi: 10.1007/978-1-4939-7498-6_25.
2
Sustained Endocrine Gland-Derived Vascular Endothelial Growth Factor Levels Beyond the First Trimester of Pregnancy Display Phenotypic and Functional Changes Associated With the Pathogenesis of Pregnancy-Induced Hypertension.妊娠前三个月后持续存在的内分泌腺源性血管内皮生长因子水平显示出与妊娠期高血压发病机制相关的表型和功能变化。
Hypertension. 2016 Jul;68(1):148-56. doi: 10.1161/HYPERTENSIONAHA.116.07442. Epub 2016 May 2.
3
Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.孕早期人胎盘中内分泌腺源性血管内皮生长因子/促胃动素-1及其受体的表达与氧调节
Endocrinology. 2006 Apr;147(4):1675-84. doi: 10.1210/en.2005-0912. Epub 2005 Dec 29.
4
Revisiting the role of hCG: new regulation of the angiogenic factor EG-VEGF and its receptors.重新审视 hCG 的作用:血管生成因子 EG-VEGF 及其受体的新调控。
Cell Mol Life Sci. 2012 May;69(9):1537-50. doi: 10.1007/s00018-011-0889-x. Epub 2011 Dec 3.
5
Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.在小鼠整个妊娠期,EG-VEGF及其受体PKR1(促动力素受体-1)和PKR2在胎盘的表达情况。
Placenta. 2007 Oct;28(10):1049-58. doi: 10.1016/j.placenta.2007.03.008. Epub 2007 May 25.
6
Interstitial trophoblastic cell fusion and E-cadherin immunostaining in the placental bed of normal and hypertensive pregnancies.正常妊娠和高血压妊娠胎盘床中间质滋养层细胞融合及E-钙黏蛋白免疫染色
Placenta. 2009 Aug;30(8):719-25. doi: 10.1016/j.placenta.2009.05.006. Epub 2009 Jul 18.
7
PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development.过氧化物酶体增殖物激活受体γ通过激活内皮生长因子-VEGF控制妊娠结局:胎盘发育机制的新见解
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E357-69. doi: 10.1152/ajpendo.00093.2015. Epub 2015 Jun 16.
8
Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.正常妊娠和子痫前期妊娠孕妇胎盘组织中血管内皮生长因子(VEGF)、内分泌腺源性VEGF及其受体的差异表达
J Clin Endocrinol Metab. 2004 May;89(5):2484-90. doi: 10.1210/jc.2003-031580.
9
Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression and .拮抗 EG-VEGF 受体作为绒癌进展和转移的靶向治疗
Clin Cancer Res. 2017 Nov 15;23(22):7130-7140. doi: 10.1158/1078-0432.CCR-17-0811. Epub 2017 Sep 12.
10
miR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9.微小RNA-346和微小RNA-582-3p通过基质金属蛋白酶2和9调节内皮糖蛋白血管内皮生长因子的表达及滋养层细胞侵袭。
Biofactors. 2017 Mar;43(2):210-219. doi: 10.1002/biof.1325. Epub 2016 Sep 13.

引用本文的文献

1
Antagonisation of Prokineticin Receptor-2 Attenuates Preeclampsia Symptoms.拮抗促动力蛋白受体-2可减轻子痫前期症状。
J Cell Mol Med. 2025 Jan;29(2):e70346. doi: 10.1111/jcmm.70346.
2
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases.靶向促动力素受体在疾病中的治疗潜力。
Pharmacol Rev. 2023 Nov;75(6):1167-1199. doi: 10.1124/pharmrev.122.000801. Epub 2023 Sep 8.
3
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy.孕期促动力蛋白受体拮抗剂安全性与有效性的循证观点
Biomedicines. 2021 Mar 17;9(3):309. doi: 10.3390/biomedicines9030309.